Startups

machineMD
Bern, Switzerland · Boston, Massachusetts, United States
machineMD is the Swiss neurodiagnostics company machine MD AG, headquartered in Bern, with a Boston subsidiary. Its own imprint identifies Swiss register CH-036.3.079.921-3 and UID CHE-143.068.099. Founded in 2019 from University of Bern and Inselspital research, it develops neos, a headset and software system for standardized measurement of eye alignment, movements, pupillary responses and visual fields. Infrared eye tracking, virtual-reality visual stimuli and cloud reports provide quantitative neuro-ophthalmic data. Its research and machine-learning team explores digital biomarkers relevant to multiple sclerosis, Parkinson’s, Alzheimer’s and other brain disorders; research associations do not establish disease-specific screening accuracy or broad diagnostic authorization. The published TÜV SÜD EU MDR certificate covers the NEOS head-mounted display and software as a Class IIa device, valid from October 7, 2024. Its June 2026 issuer article describes US FDA Class I registration, which is recorded as a company-stated registration claim and not FDA approval or clearance. The complete published directory contains four board members, four external medical advisers and thirty named team members; listed concurrent HR leadership is preserved as published rather than assuming a departure. Financing includes the contemporary December 2021 CHF1.4M convertible-loan closing, September 2022 CHF3.2M seed led by Guido Fluri Foundation, and Topcon Healthcare’s March 2025 pre-Series A investment. A later CHF1.2M description of the 2021 note is a conflicting retrospective conversion figure, not additional cash. Collaborative research grants are recorded with unknown company allocations; consortium budgets, grant programme caps and proposed round targets are not machineMD proceeds.
Founded 2019





































